簡易檢索 / 詳目顯示

研究生: 黃阡崧
Huang, Cian-Song
論文名稱: 酵素水解果膠物協同順鉑抑制人類肺癌及肝癌細胞之研究
Synergistic antitumor effect of enzyme-hydrolyzed pectin and cisplatin against human lung cancer and liver cancer cells
指導教授: 吳明昌
Wu, Ming-Chang
學位類別: 博士
Doctor
系所名稱: 農學院 - 食品科學系所
Department of Food Science
畢業學年度: 107
語文別: 中文
論文頁數: 84
中文關鍵詞: 順鉑酵素處理果膠協同效應輔助治療
外文關鍵詞: cisplatin, enzyme treated pectin, synergistic effect, adjuvant therapy
DOI URL: http://doi.org/10.6346/DIS.NPUST.FS.001.2019.E11
相關次數: 點閱:29下載:2
分享至:
查詢本校圖書館目錄 查詢臺灣博碩士論文知識加值系統
  • 順鉑 (DDP)為目前臨床上常使用的抗腫瘤藥物,但也伴隨著嚴重副作用,本研究主要探討酵素水解果膠物 (PET)聯合DDP對人類肺癌及肝癌細胞之影響,酵素水解果膠物聯合DDP作用A549及HepG2可抑制細胞生長且具有協同作用、改變細胞週期分布、增強細胞凋亡反應,其中DDP 12h+PET 12h 順序聯合治療組效果最好,西方墨點分析顯示PET與DDP組合處理可增強Bax、p53、p38及Caspase-3蛋白,並降低Bcl-2蛋白。更重要的是,使用PET和DDP組合處理方式可減弱DDP對於正常HEK293腎細胞誘導的毒性。我們的數據顯示,使用天然來源的PET聯合DDP處理有助於成為肺癌和肝癌的一種新輔助治療的重要方式,這也降低DDP對腎毒性和延緩DDP耐藥性的發展提供重要資訊。

    Cisplatin (DPP), a clinically potent antineoplastic agent, is limited by its severe adverse effects. The aim of this study was to investigate the effect of pectin enzyme treated pectin (PET) and DDP on human lung cancer A549 cells and liver cancer HepG2 cells. The combined use of PET and DDP had a synergistic effect on the growth inhibition of A549 cells and HepG2 cells, changed the cell cycle distribution, and enhanced apoptotic response, especially in sequential combination treatment group of DDP 12 h + PET 12 h. Western blot analyses showed that the combination treatment of PET and DDP upregulated Bax, p53, p38, and Caspase-3 and downregulated Bcl-2 proteins. More importantly, DDP-induced toxicity was attenuated by PET and DDP combination treatment in normal HEK293 cells. Our data suggests that the combined use of PET from natural sources and DDP could be an important new adjuvant therapy for lung cancer and liver cancer as well as offer important insights for reducing kidney toxicity of DDP and delaying the development of DDP resistance.

    中文摘要---I
    Abstract-------------------------------------------- II
    致謝------------------------------------------------ III
    目錄------------------------------------------------ IV
    圖目錄---------------------------------------------- VII
    表目錄-----------------------------------------------IX
    第一章 前言-------------------------------------------1
    第二章 文獻回顧----------------------------------------2
    2.1 果膠---------------------------------------------2
    2.1.1果膠分解酵素--------------------------------------2
    2.1.2修飾化果膠----------------------------------------3
    2.1.3修飾化果膠抑癌探討---------------------------------7
    2.2惡性腫瘤-------------------------------------------10
    2.2.1肺癌---------------------------------------------10
    2.2.2肝癌---------------------------------------------10
    2.3順鉑 (Cisplatin, DDP) -----------------------------11
    2.3.1順鉑作用機制--------------------------------------11
    2.3.2順鉑副作用----------------------------------------11
    2.4細胞死亡--------------------------------------------13
    2.4.1細胞壞死------------------------------------------13
    2.4.2細胞凋亡------------------------------------------13
    2.4.3細胞凋亡之調控機制---------------------------------13
    第三章 材料與方法---------------------------------------15
    3.1 實驗架構------------------------------------------15
    3.2 實驗試藥------------------------------------------16
    3.3 儀器設備------------------------------------------20
    3.4 酵素水解果膠製備-----------------------------------22
    3.5 TEAC總抗氧化能力分析-------------------------------22
    3.6 DPPH清除自由基能力分析-----------------------------22
    3.7 細胞培養------------------------------------------23
    3.7.1 樣品製備-----------------------------------------23
    3.7.2 細胞活化-----------------------------------------23
    3.7.3 細胞繼代-----------------------------------------23
    3.7.4 細胞計數-----------------------------------------24
    3.7.5 細胞凍管保存-------------------------------------24
    3.8 細胞抑制率分析 (MTT assay) ------------------------24
    3.9 乳酸脫氫酶活性分析 (LDH assay) ---------------------25
    3.10 細胞型態觀察--------------------------------------26
    3.11 DAPI染色螢光顯微鏡觀察-----------------------------26
    3.12 細胞週期分析--------------------------------------26
    3.13 細胞凋亡分析--------------------------------------27
    3.14 Galectin-3分析-----------------------------------27
    3.15 西方墨點法 (Western Blot) ------------------------28
    3.15.1 細胞蛋白質萃取----------------------------------28
    3.15.2 蛋白質電泳分析----------------------------------28
    3.15.3 轉印及免疫染色法--------------------------------29
    3.16 彗星實驗 (Comet assay) --------------------------29
    3.17 統計分析-----------------------------------------30
    第四章 結果與討論--------------------------------------31
    4.1 不同果膠濃度經由商業果膠酵素水解之抗氧化能力表現------31
    4.2 PET對人類肺癌肝癌細胞及正常腎細胞之生長抑制影響-------34
    4.3 PET與DDP對人類癌細胞及正常腎細胞之生長抑制影響--------34
    4.4 PET與DDP對人類癌細胞及正常腎細胞之細胞膜通透性影響----42
    4.5 PET與DDP處理對細胞之形態變化------------------------44
    4.6 PET和DDP聯合作用對細胞週期分佈和細胞凋亡之影響--------51
    4.7 PET和DDP聯合作用對Galectin-3含量影響----------------57
    4.8 PET和DDP協同作用之機制探討--------------------------59
    4.9 PET和DDP聯合作用之彗星試驗--------------------------70
    第五章 結論--------------------------------------------73
    參考文獻-----------------------------------------------75
    作者簡介-----------------------------------------------82

    沈郁婷。2008。半枝蓮對人類肺癌細胞在體外與肺癌小鼠模式抗腫瘤作用之研究。國立成功大學微生物及免疫學研究所碩士論文。
    林育正。2012。果膠之酵素水解物抑制癌細胞之研究。國立屏東科技大學食品科學系碩士論文。
    林祐賢,林勝豐,蕭惠樺,劉益昌,楊文祺,黃道揚,洪啟智,黃尚志,顧進裕,陳鴻鈞。2011。順鉑造成急性腎損傷之最新進展。內科學誌。22: 416-422。
    侯竣程。2017。連翹抑制黑色素形成及促進黑色素瘤凋亡。國立屏東科技大學食品科學系碩士論文。
    施秉孝。2004。花青素誘發人類胃腺癌細胞凋亡之分子機轉。國立中興大學食品學系碩士論文。
    陳佩君。2005。樟芝菌絲體醣蛋白Antrodan合併順鉑在小鼠異體移植肺癌細胞株 (LLC1)之模式中抑制腫瘤轉移並改善順鉑的腎毒性。國立中興大學食品暨應用生物科技學系碩士論文。
    黃評脩。2005。以再酯化CL-AIS分離商業果膠酵素之果膠解離酶降低黑後葡萄酒中甲醇含量之研究。國立屏東科技大學食品科學系碩士論文。
    黃評脩。2012。酵素修飾果膠之抗氧化、氧化安定性與抑癌能力之探討。國立屏東科技大學食品科學系博士論文。
    潘思妤。2009。修飾化愛玉果膠及其水解產物對人類胃癌細胞 (AGS)之影響。國立屏東科技大學食品科學系碩士論文。
    賴俊凱。2007。探討HepG2肝癌細胞受到肝臟生長因子誘發KLF4表現的現象。國立中興大學生命科學系碩士論文。

    Astolfi L, Ghiselli S, Guaran V, Chicca M, Simoni E, Olivetto E, Lelli G, Martini A. 2013. Correlation of adverse effects of cisplatin administration in patients affected by solid tumours: a retrospective evaluation. Oncology Reports. 29: 1285–1292.
    Cameron RG, Savary BJ, Iiotchkiss AT, Fishman ML, Chau IK, Backer RA, Grohmann K. 2003. Separation and characterization of a salt-dependent pectin methylesterase from citrus sinensis Var. valencia fruit tissue. Journal of Agricultural and Food Chemistry. 51: 2070–2075.
    Chan FK, Moriwaki K, De Rosa MJ. 2013. Detection of necrosis by release of lactate dehydrogenase activity. Methods in Molecular Biology. 979: 65–70.
    Chazotte B. 2011. Labeling nuclear DNA using DAPI. Cold Spring Harb. Protoc. 2011: pdb.prot5556.
    Chen CH, Sheu MT, Chen TF, Wang YC, Hou WC, Liu DZ, Chung TC, Liang YC. 2006. Suppression of endotoxin-induced proinflammatory responses by citrus pectin through blocking LPS signaling pathways. Biochemical Phamamacology. 72: 1001–1009.
    Cho Y, Kim H, Turner ND, Mann JC, Wei J, Taddeo SS, Davidson LA, Wang N, Vannucci M, Carroll RJ, Chapkin RS, Lupton JR. 2011. A chemoprotective fish oil and pectin-containing diet temporally alters gene expression profiles in exfoliated rat colonocytes throughout oncogenesis. The Journal of Nutrition. 141: 1029–1035.
    Delphi L, Sepehri H, Physiology A. 2016. Apple pectin: A natural source for cancer suppression in 4T1 breast cancer cells in vitro and express p53 in mouse bearing 4T1 cancer tumors, in vivo. Biomedicine and Pharmacotherapy. 84: 637–644.
    Duan G, Tang Q, Yan H, Xie L, Wang Y, Zheng XE, Zhuge Y, Shen S, Zhang B, Zhang X, Wang J, Wang W, Zou X. 2017. A strategy to delay the development of cisplatin resistance by maintaining a certain amount of cisplatin-sensitive cells. Scientific Reports. 7: 432.
    Fachin D, Van Loey AM, Nguyen BL, Indrawati IV, Hendrickx ME. 2003. Inactivation kinetics of polygalacturonase in tomato juice. Innovative Food Science and Emerging Technologies. 4: 135–142.
    Gao LP, Li Z, Guo ZY, Zhao YM. 2013. The effects of vitamin C on DDP-induced anemia in rats. Toxicology Mechanisms and Methods. 23: 383–388.
    Gummadi SN, Panda T. 2003. Purification and biochemical properties of microbial pectinases-a review. Process Biochemistry. 38: 987–996.
    Hayashi A, Gillen AC, Lott JR. 2000. Effects of Daily Administration of Quercetin Chalcone and Modified Citrus Pectin on Implanted Colon-25 Tumor Growth in Balb-c Mice. Altternative Medicine Review. 5: 536–52.
    Ho YY, Lin CM, Wu MC. 2017. Evaluation of the prebiotic effects of citrus pectin hydrolysate. Journal of Food and Drug Analysis. 25: 550–558.
    Huang CS, Huang AC, Huang PH, Lo D, Wang YT, Wu MC. 2018. Synergistic antitumor effect of oligogalacturonides and cisplatin on human lung cancer A549 cells. International Journal of Molecular Sciences. 19: 1769.
    Huang PH, Fu LC, Huang CS, Wang YT, Wu MC. 2012. The uptake of oligogalacturonide and its effect on growth inhibition, lactate dehydrogenase activity and galactin-3 release of human cancer cells. Food Chemistry. 132: 1987–1995.
    Huang PH, Lu HT, Wang YT, Wu MC. 2011. Antioxidant activity and emulsion stabilizing effect of pectic enzyme treated pectin in soy protein isolate-stabilized oil/water emulsion. Journal of Agricultural and Food Chemistry. 59: 9623–9628.
    Jackson CL, Dreaden TM, Theobald LK, Tran NM, Beal TL, Eid M, Gao MY, Shirley RB, Stoffel MT, Kumar MV, Mohnen D. 2007. Pectin induces apoptosis in human prostate cancer cells: correlation of apoptotic function with pectin structure. Glycobiology. 17: 805–819.
    Jayani RS, Saxena S, Gupta R. 2005. Microbial pectinolytic enzymes: A review. Process Biochemistry. 40: 2931–2944.
    Kashyap DR, Vohra PK, Chopra S, Tawari R. 2001. Applications of pectinases in the commercial sector: a review. Bioresource Technology. 77: 215–227.
    Kosmider B, Zawlik I, Liberski PP, Osiecka R, Zyner E, Ochocki J, Bartkowiak J. 2006. Evaluation of P53 and BAX gene expression and induction of apoptosis and necrosis by the cis-Pt (II) complex of 3-aminoflavone in comparison with cis-diamminedichloroplatinum (II) (cis-DDP) in human lymphocytes. Mutation Research. 604: 28–35.
    Kyriakidis NB. 1999. Use of pectinesterase for detection of hydrocolloids addition in natural orange juice. Food Hydrocolloids. 19: 497–500.
    Leclere L, Van Cutsem P, Michiels C. 2013. Anti-cancer activities of pH-or heat-modified pectin. Frontiers in Pharmacology. 4, 128.
    Liu W, Li J, Hu Y, Qian G. 2002. Cisplatin-induced apoptosis in human lung adenocarcinoma cell line A549. Zhongguo Fei Ai Za Zhi. 5: 254–256.
    Maxwell EG, Belshaw N, Waldron KW and Morris VJ. 2012. Pectin An emerging new bioactive food polysaccharide. Trends in Food Science and Technology. 24: 64–73.
    Mosmann T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of Immunological Methods. 65: 55–63.
    Nangia-Makker P, Hogan V, Honjo Y, Baccarini S, Tait L, Bresalier R, Raz A. 2002. Inhibition of Human Cancer Cell Growth and Metastasis in Nude Mice by Oral Intake of Modified Citrus Pectin. Journal of the National Cancer Institute. 94: 1853–1862.
    Ogutu FO, Mu TH. 2017. Ultrasonic degradation of sweet potato pectin and its antioxidant activity. Ultrasonics Sonochemistry. 38: 726–734.
    Pirman T, Ribeyre MC, Mosoni L, Rémond D, Vrecl M, Salobir J, Patureau Mirand P. 2007. Dietary pectin stimulates protein metabolism in the digestive tract. Nutrition. 23:69–75.
    Platt D, Raz A. 1992. Modulation of the lung colonization of B16-F1 melanoma cells by citrus pectin. Journal of National Cancer Institute. 86: 438–442.
    Raz A. 2000. Modified citrus pectin-monograph. Alternative Medicine Review. 5: 573–575.
    Siddik ZH. 2003. Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene. 22: 7265–7279.
    Vassilopoulos A, Xiao C, Chisholm C, Chen W, Xu X, Lahusen TJ, Bewley C, Deng CX. 2014. Synergistic therapeutic effect of cisplatin and phosphatidylinositol 3-kinase (PI3K) inhibitors in cancer growth and metastasis of Brca1 mutant tumors. The Journal of Biological Chemistry. 289: 24202–24214.
    Vermes I, Haanen C. 1994. Apoptosis and programmed cell death in health and disease. Advances in Clinical Chemistry. 31: 177–246.
    Wang S, Li P, Lu SM, Ling ZQ. 2016. Chemoprevention of low-molecular-weight citrus pectin (LCP) in gastrointestinal cancer cells. International Journal of Biological Sciences. 12: 746–756.
    Wu MC, Jiang CM, Huang PH, Wu MY and Wang YT. 2007. Separation and utilization of pectin lyase from commercial pectic enzymes via HM-CL-AIS for wine methanol reduction. Journal of Agricultural and Food Chemistry. 55: 1557–1562.
    Yamada H. 1996. Contribution of pectins on health care. Progress in Biotechnology. 14: 173–190.
    Yang M, Xiang G, Li D, Zhang Y, Xu W, Tao L. 2016. The insecticide spinosad induces DNA damage and apoptosis in HEK293 and HepG2 cells. Mutation Research. 812: 12–19.
    Yang Q, He X, Li X, Xu W, Luo Y, Yang X, Wang Y, Li Y, Huang K. 2014. DNA damage and S phase arrest induced by Ochratoxin A in humanembryonic kidney cells (HEK 293). Mutation Research. 765: 22–31.
    Yang SS, Cheng KT, Lin YS, Liu YW, Hou WC. 2004. Pectin hydroxamic acids exhibit antioxidant activities in vitro. Journal of Agriculture and Food Chemistry. 52: 4270–4273.
    Ye MB, Lim BO. 2010. Dietary pectin regulates the levels of inflammatory cytokines and immunoglobulins in interleukin-10 knockout mice. Journal of Agricultural and Food Chemistry. 58: 11281–11286.
    Ye MX, Zhao YL, Li Y, Miao Q, Li ZK, Ren XL, Song LQ, Yin H, Zhang J. 2012. Curcumin reverses cis-platin resistance and promotes human lung adenocarcinoma A549/DDP cell apoptosis through HIF-1α and caspase-3 mechanisms. Phytomedicine. 19: 779–787.
    Zamble DB, Jacks T, Lippard SJ. 1998. p53-Dependent and -independent responses to cisplatin in mouse testicular teratocarcinoma cells. Proceedings of the National Academy of Sciences of the United States of America. 95: 6163–6168.
    Zeidan YH, Jenkins RW, Hannun YA. 2008. Remodeling of cellular cytoskeleton by the acid sphingomyelinase/ceramide pathway. The Journal of Cell Biology. 181: 335–350.

    下載圖示
    QR CODE